This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Uric acid levels in acute gout

Authoring team

Uric acid levels in acute gout

  • serum urate levels should be checked to confirm hyperuricaemia and to monitor response to treatment
    • however, a degree of caution is required in interpreting the results. Serum urate levels tend to decrease during an acute attack of gout and rise again as inflammation settles
    • therefore
      • if the serum urate level is found to be normal during a suspected attack of gout it should be repeated once the attack has resolved
    • NICE state (2):
      • measure the serum urate level in people with symptoms and signs of gout to confirm the clinical diagnosis (serum urate level of 360 micromol/litre [6 mg/dl] or more) (1)
        • if serum urate level is below 360 micromol/litre (6 mg/dl) during a flare and gout is strongly suspected, repeat the serum urate level measurement at least 2 weeks after the flare has settled

Conversely, as most people with hyperuricaemia do not develop gout, concurrent joint symptoms and hyperuricaemia should not be considered to equate with gout unless the clinical presentation is typical or MSU crystals have been identified on aspirated synovial fluid. Renal function should also be assessed.

Reference:

  1. Arthritis Research UK (2011). Hands On (9) - gout: presentation and management in primary care
  2. NICE (June 2022). Gout: diagnosis and management

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.